Akeso Therapeutics, Inc. Announces Appointment of Steven A. Porcelli, MD, to…
Yorktown Heights, N.Y., May 17, 2022 (GLOBE NEWSWIRE) -- Akeso Therapeutics, Inc., an early-stage biotechnology company developing engineered natural killer T (NKT) cells for the…